New iBIO & iBIO Institute President & CEO Announced
January 06, 2015
Warren Ribley Named President & CEO of iBIO and the iBIO Institute
Ideal Fit for Next Phase of iBIO’s Growth
CHICAGO, IL – The Illinois Biotechnology Industry Organization - better known as iBIO® - and its affiliate, the iBIO® Institute, today announced that Warren Ribley, has been named President & CEO of both organizations. He will assume his new responsibilities at the beginning of February, 2015.
Appointed to lead the Illinois Medical District in April of 2012, Ribley is widely credited with revitalizing the District and attracting new tenants and life sciences developments, including the University of Illinois’ Health Technology Innovation center (HTI). Before taking over leadership of the IMD, he spent three years as the head of Illinois’ economic development agency, the Illinois Department of Commerce and Economic Opportunity (DCEO). While he was at DCEO, the agency invested in over 150 companies, many of them in emerging technological fields. He also successfully implemented the jobs-building Angel Tax Credit for startup technology firms. In 2010 he won iBIO’s John W. Maitland Award for Leadership in Biotechnology because of his commitment to the successful BIO International Convention in Chicago and for his steadfast support of the nationally recognized PROPEL® Center for entrepreneurs at the iBIO Institute.
"Warren Ribley has repeatedly demonstrated outstanding leadership and support for biotechnology in Illinois,” said iBIO Board Chairman Andy Hull, Vice President for Global Alliances at Takeda Pharmaceuticals North America, who led the iBIO / iBIO Institute Search Committee comprised of executive leaders in both organizations. "Our boards of directors are convinced he has the unique skill set and experience to accelerate our mission of making this region a top global biotech center,” he added.
Linda Friedman, Esq., Chairperson of the iBIO Institute Board of Directors and Senior V.P. General Counsel and Corporate Secretary of Astellas US, LLC, commented "In conducting our search, we wanted a proven leader who will continue our strong focus in each of our key sectors—agriculture, bio-industrial, and bio-medical-with an emphasis on early stage innovative companies and education. Warren brings that understanding and focus to the job with a proven track record based on decades of service to our state.”
Ribley succeeds outgoing iBIO and iBIO Institute President & CEO, David Miller, who has led the iBIO organizations for over twelve years and last year announced his plans to retire in early 2015. Miller praised the choice of his successor, stating "Warren clearly cares deeply about the wondrous things our ag, bio-industrial and medical communities are accomplishing on a daily basis. I have great confidence in his ability to lead the community, and he has my complete support going forward.”
"I am deeply honored by the trust placed in me by the iBIO and iBIO Institute Boards,” commented Ribley. He added, "iBIO and the iBIO Institute have put Illinois on the global biotech map for their successes in public policy, STEM education reform, support for entrepreneurs, and community building. I welcome the challenge of expanding on the strong track record they have already established.”